The Erythrocyte-Coating Substance in Autoimmune Hemolytic Disease: Its Nature and Significance
- 1 March 1958
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 13 (3) , 201-215
- https://doi.org/10.1182/blood.v13.3.201.201
Abstract
The life span of erythrocytes in autoimmune hemolytic disease is inversely proportional to the concentration of erythrocyte-coating substance. After cortico-steroid therapy the life span was increased. The erythrocyte-coating substance in autoimmune hemolytic disease is either a gamma globulin or a substance cross reacting with it No difference was noted in the reactivity of the erythrocyte coating substance in autoimmune hemolytic disease of the idiopathic or of the symptomatic variety. The hemolytic anemia of the hematologic malignancies with negative Coombs'' test is presumably nonimmune in origin.Keywords
This publication has 3 references indexed in Scilit:
- The Present Status of Treatment of Autoimmune Hemolytic Anemia with ACTH and CortisoneBlood, 1956
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951
- SYMPTOMATIC HEMOLYTIC ANEMIAAnnals of Internal Medicine, 1941